The Institute of Inflammation, Immunology and Infectious Disease at Purdue University has partnered with Cleveland-based technology firm IdentifySensors Biologics to develop a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, the virus that causes COVID-19.
MEDIA & PRESS INQUIRES
CONNECT WITH IDENTIFYSENSORS
Communications: Joe Mosbrook
(216) 375-2141
mosbrook@acclaimllc.com
Related Articles
IdentifySensors Technology Platform uses Electronic Nanosensors to Detect Genetic Materials
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
IdentifySensors Develops Fast, Accurate, Over-the-counter RNA Self-test
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
IdentifySensors Biologics Moves New Pathogen Testing Platform To Commercialization Stage
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles